Dashboard
Discussions
Watchlists
Collections
Tools
More
Events
SIGN UP
SIGN IN
ENTITY
Simcere Pharmaceutical Group (2096 HK)
Watchlist
53
Analysis
Health Care
•
China
Simcere Pharmaceutical Group manufactures and supplies branded generic pharmaceuticals to the China market. The Company's products include antibiotics, anti-cancer medications and anti-stroke medications.
more
Watchlist
All
Insights
Broker
Sponsored
Syndicated
Podcast
Buy side
Refresh
Focused
Suggested
bullish
•
Simcere Pharmaceutical Group
•
04 Jan 2022 23:48
Simcere Pharmaceutical (2096 HK): Focus Shifts to Innovative Drug; COVID-19 Oral Drug in Development
Simcere is expected to continue strong performance driven by increasing contribution of innovative drugs. Rich pipeline entails visibility. The...
Tina Banerjee
Follow
245 Views
Share
bullish
•
Thematic (Sector/Industry)
•
28 Dec 2021 09:05
Oral COVID-19 Antivirals and the Impact on China
This insight analyzed Pfizer's Paxlovid and Merck’s Molnupiravir after FDA EUA, the global market potential, the impact on China market and related...
Xinyao (Criss) Wang
Follow
370 Views
Share
bearish
•
Alphamab Co Ltd
•
15 Dec 2021 09:14
Alphamab Co Ltd (9966.HK) - Some Points Worth the Attention
The article analyzed Alphamab Oncology in terms of its conservativeness on business operation and decision making in early stages, the concerns on...
Xinyao (Criss) Wang
Follow
235 Views
Share
bearish
•
3D Medicines
•
24 Aug 2021 09:08
Pre-IPO 3D Medicines - Insights on the Core Product, the Pipeline and the Concerns
This insight mainly analyzed 3D Medicines in terms of its core product envafolimab (the competition pattern and prospects), clinical-stage product...
Xinyao (Criss) Wang
Follow
266 Views
Share
bullish
•
Sihuan Pharmaceutical Hldgs
•
01 Jun 2021 09:07
Sihuan Pharmaceutical (460.HK) - Optimistic in the Short Term but Conservative in the Long Term
The medical beauty business outlook with high certainty is the main reason for the share price to rise three times this year.However, there are...
Xinyao (Criss) Wang
Follow
175 Views
Share
First
Previous
4
5
6
7
8
9
10
Next
Last
Copyright © 2022 Smartkarma Innovations Pte Ltd. All Rights Reserved. v3.33.1
x